Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer (NCT01303029)Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)2011-02-01
N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement (NCT01704482)Assiut University2011-02-01
A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder. (NCT01288079)AstraZeneca2011-02-01
A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer (NCT01228045)National University Hospital, Singapore2011-02-01
WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation (NCT01334060)University Hospital Southampton NHS Foundation Trust2011-02-01
Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia (NCT00906945)Washington University School of Medicine2011-02-01
Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy (NCT01319669)Chinese Society of Lung Cancer2011-02-01
Trial of MK-2206 + Endocrine Treatment in Patients With Hormone Receptor Positive Breast Cancer (NCT01240941)Vanderbilt-Ingram Cancer Center2011-02-01
Canakinumab for Pyoderma Gangrenosum (NCT01302795)University of Zurich2011-02-01
A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA) (NCT01285752)Asahi Kasei Therapeutics Corporation2011-02-01
Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation (NCT01288235)Massachusetts General Hospital2011-02-01
Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin (NCT01059305)M.D. Anderson Cancer Center2011-02-01
Exploratory Study to Evaluate 2 Acupuncture Methods for the Treatment of Headaches Associated With TBI (NCT01338701)Samueli Institute for Information Biology2011-02-01
Oral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCT (NCT01523834)Fondazione Italiana Linfomi - ETS2011-02-01
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection (NCT01191840)Duke University2011-02-01
A Human Trial to Evaluate the Efficacy and Safety of Fermented Turmeric in Subjects Showing Mild Hepatic Injury (NCT01634256)Chonbuk National University Hospital2011-02-01
Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks (NCT01218802)University Hospitals Cleveland Medical Center2011-02-01
Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC (NCT02175381)Hellenic Oncology Research Group2011-02-01
Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients. (NCT01745744)Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud2011-02-01
Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation (NCT01259622)Sequel Pharmaceuticals, Inc2011-02-01
A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) (NCT01281631)Neuraltus Pharmaceuticals, Inc.2011-02-01
Effect of Low-Magnitude, High Frequency Vibration Treatment on Femoral Shaft Fracture Healing (NCT01386749)Chinese University of Hong Kong2011-02-01
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT) (NCT01244503)Virginia Commonwealth University2011-02-01
Effects of Dronabinol (Oral THC) on Cannabis Use (NCT01394185)Johns Hopkins University2011-02-01
Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment (NCT01285401)Merck KGaA, Darmstadt, Germany2011-02-01
Bevacizumab in Recurrent Grade II and III Glioma (NCT01164189)European Organisation for Research and Treatment of Cancer - EORTC2011-02-01
Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology. (NCT01292551)Rigshospitalet, Denmark2011-02-01
Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine (NCT01316406)Advancell - Advanced In Vitro Cell Technologies, S.A.2011-02-01
Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma (NCT01307618)National Cancer Institute (NCI)2011-02-01
Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 (NCT01419470)Yuhan Corporation2011-02-01
Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study (NCT02092961)AstraZeneca2011-02-01
Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL) (NCT01300156)National Cancer Center, Korea2011-02-01
Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer (NCT01167192)Washington University School of Medicine2011-02-01
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT01266447)National Cancer Institute (NCI)2011-02-01
Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients (NCT02285413)Radboud University Medical Center2011-02-01
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia (NCT01408732)University of Minnesota2011-02-01
Nalrexone Facilitated Discontinuation of Buprenorphine (NCT01895036)New York State Psychiatric Institute2011-02-01
Conventional Versus Virtual Reality Based Vestibular Rehabilitation (NCT01442623)Royal College of Surgeons, Ireland2011-02-01
Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI) (NCT01306968)U.S. Army Medical Research and Development Command2011-02-01
Dexmedetomidine to Lessen Intensive Care Unit (ICU) Agitation (NCT01151865)Austin Health2011-02-01
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population (NCT01313663)GlaxoSmithKline2011-02-01
Internet-based Cognitive Behavior Therapy (CBT) for Obsessive Compulsive Disorder (OCD) (NCT01347099)Karolinska Institutet2011-02-01
Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) (NCT01096732)Lisa Bax2011-02-01
A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) (NCT01318434)Euthymics BioScience, Inc.2011-02-01
A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke (NCT01297413)Stemedica Cell Technologies, Inc.2011-02-01
Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors (NCT01234922)Wake Forest University Health Sciences2011-02-01
MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy (NCT01290224)Mayo Clinic2011-02-01
Comparison of the Shang Ring With Conventional Surgical Methods (NCT01300910)FHI 3602011-02-01
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms (NCT01194440)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2011-02-01
Waterjet Versus Ultrasound Dissection During Hepatic Transection (NCT02041065)Karolinska University Hospital2011-02-01
Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus (NCT01294774)Novartis Pharmaceuticals2011-02-01
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia (NCT01154816)Children's Oncology Group2011-02-01
Cortisone Treatment for the Prevention of Postoperative Pancreatitis and Pancreatitis-induced Complications After Pancreaticoduodenectomy and Distal Pancreatic Resection (NCT01460615)Tampere University Hospital2011-02-01
Glutamatergic Modulation of Cocaine-related Deficits (NCT01790490)New York State Psychiatric Institute2011-02-01
Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases (NCT01442935)UNICANCER2011-02-01
Xolair Enhances Oral Desensitization in Peanut Allergic Patients (NCT01290913)Lynda Schneider2011-02-01
LYmphadenectomy After NeoAdjuvant Chemotherapy (NCT01724944)Catholic University of the Sacred Heart2011-02-01
ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT01218048)Robert Ferris2011-02-01
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection (NCT01306617)AbbVie (prior sponsor, Abbott)2011-02-01
Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy (NCT02049047)Armando Santoro, MD2011-02-01
Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis (NCT01277315)Charite University, Berlin, Germany2011-02-01
A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain (NCT01266967)GlaxoSmithKline2011-02-01
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy (NCT01287897)Pfizer2011-02-01
Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+) (NCT01221376)Renato Melaragno2011-02-01
JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin (NCT01599013)Pierre Fabre Medicament2011-02-01
Effects of Transcutaneous Electrical Diaphragmatic Stimulation on Respiratory Variables in COPD Patients (NCT01300442)Universidade Federal de Sao Carlos2011-02-01
The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone (NCT01279187)University of Michigan2011-02-01
A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia (NCT01234779)Hoffmann-La Roche2011-02-01
A Study in Non Small Cell Lung Cancer (NCT01139775)Eli Lilly and Company2011-02-01
Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis (NCT01289431)Bausch & Lomb Incorporated2011-02-01
Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers (NCT01273272)University of Zurich2011-02-01
A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer (NCT01201265)Hoffmann-La Roche2011-02-01
Healthy Homes/Healthy Families (NCT01326897)Emory University2011-02-01
Oral Curcumin for Radiation Dermatitis (NCT01246973)University of Rochester2011-02-01
Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease (NCT01354691)Avraham Pharmaceuticals Ltd2011-02-01
Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy (NCT02062034)University of Guadalajara2011-02-01
Strengthening Families and Reducing Risk Thru Developmental and Legal Collaboration (NCT01343940)Boston Medical Center2011-02-01
Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC). (NCT01798147)Johannes Gutenberg University Mainz2011-02-01
Amitriptyline Regarding Nimesulide in Acute Idiopathic Adhesive Capsulitis (NCT01306708)Universidade do Sul de Santa Catarina2011-02-01
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC. (NCT01291017)University of Florida2011-02-01
Saffron Supplementation in Stargardt's Disease (NCT01278277)Catholic University of the Sacred Heart2011-02-01
Essential Hypertension (NCT01264692)Idorsia Pharmaceuticals Ltd.2011-02-01
Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer (NCT02119026)Prof. Dr. Werner Scheithauer2011-02-01
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer (NCT00979212)Radiation Therapy Oncology Group2011-02-01
Vitamin D3 Supplementation in Dialysis Patients (NCT01312714)Regional Hospital Holstebro2011-02-01
Spectrophotometric Evaluation of Chlorhexidine Pigmentations After Oral Surgery: a Prospective Randomized Clinical Trial (NCT02132546)dott. Lorenzo Bevilacqua2011-02-01
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) (NCT01253161)H. Lee Moffitt Cancer Center and Research Institute2011-02-01
The Effect of Virtual Reality Glasses on Labor Pain (NCT01687933)Mashhad University of Medical Sciences2011-02-01
Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer (NCT01203735)Soroka University Medical Center2011-02-01
Relationship Between Treatment With Bach´s Flower Remedy and Spiritual Well-Being of People With Common Mental Disorder (NCT01324674)UPECLIN HC FM Botucatu Unesp2011-02-01
Orthomolecular Therapy and Asthma in Children (NCT00672529)Canadian Institute of Natural and Integrative Medicine2011-02-01
Varenicline for Alcohol Dependence (NCT01146613)National Institute on Alcohol Abuse and Alcoholism (NIAAA)2011-02-01
Phase II Proof-of-concept Study of APD421 (NCT01303978)Acacia Pharma Ltd2011-02-01
FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI) (NCT01426555)Antonio Lazzari2011-02-01
A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients (NCT01280695)Metabolic Solutions Development Company2011-02-01
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer (NCT01191697)Dana-Farber Cancer Institute2011-02-01
A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Negative Breast Cancer (NCT01268150)Eisai Inc.2011-02-01
Intracoronary Human Wharton's Jelly- Derived Mesenchymal Stem Cells (WJ-MSCs) Transfer in Patients With Acute Myocardial Infarction (AMI) (NCT01291329)Navy General Hospital, Beijing2011-02-01
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure (NCT01300650)Virginia Commonwealth University2011-02-01
Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients (NCT01291810)Neovacs2011-02-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.